X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11952) 11952
Newsletter (356) 356
Newspaper Article (136) 136
Book Chapter (134) 134
Magazine Article (112) 112
Transcript (9) 9
Dissertation (7) 7
Web Resource (4) 4
Publication (3) 3
Reference (3) 3
Book / eBook (2) 2
Book Review (2) 2
Streaming Video (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9730) 9730
science & technology (7723) 7723
life sciences & biomedicine (7557) 7557
warfarin (7109) 7109
male (5397) 5397
female (5162) 5162
warfarin - administration & dosage (5159) 5159
anticoagulants - administration & dosage (4442) 4442
aged (3932) 3932
middle aged (3682) 3682
warfarin - therapeutic use (3386) 3386
anticoagulants - therapeutic use (3072) 3072
anticoagulants (3009) 3009
warfarin - adverse effects (2892) 2892
anticoagulants - adverse effects (2801) 2801
cardiovascular system & cardiology (2425) 2425
adult (2369) 2369
administration, oral (2054) 2054
atrial fibrillation (2053) 2053
abridged index medicus (2018) 2018
risk factors (2013) 2013
international normalized ratio (1815) 1815
pharmacology & pharmacy (1683) 1683
aged, 80 and over (1680) 1680
treatment outcome (1626) 1626
dosage and administration (1606) 1606
atrial fibrillation - drug therapy (1578) 1578
cardiac & cardiovascular systems (1569) 1569
stroke (1442) 1442
general & internal medicine (1384) 1384
hemorrhage - chemically induced (1376) 1376
hematology (1302) 1302
retrospective studies (1263) 1263
medicine, general & internal (1251) 1251
stroke - prevention & control (1217) 1217
drug therapy (1215) 1215
peripheral vascular disease (1173) 1173
thromboembolism (1125) 1125
care and treatment (1092) 1092
drug interactions (1058) 1058
atrial fibrillation - complications (1055) 1055
anticoagulation (995) 995
dose-response relationship, drug (969) 969
time factors (966) 966
research (945) 945
analysis (905) 905
warfarin - pharmacology (893) 893
thromboembolism - prevention & control (865) 865
medicine & public health (820) 820
patients (816) 816
health aspects (785) 785
animals (776) 776
thrombosis (758) 758
prothrombin time (723) 723
complications and side effects (685) 685
bleeding (684) 684
blood coagulation - drug effects (684) 684
follow-up studies (678) 678
warfarin - pharmacokinetics (674) 674
hemorrhage (672) 672
prospective studies (668) 668
surgery (668) 668
prevention (662) 662
dabigatran (660) 660
drug administration schedule (651) 651
stroke - etiology (650) 650
cardiac arrhythmia (628) 628
drug therapy, combination (599) 599
rivaroxaban (597) 597
anticoagulants - pharmacology (587) 587
cardiology (586) 586
aspirin (575) 575
anticoagulants - pharmacokinetics (568) 568
risk assessment (567) 567
heparin - administration & dosage (560) 560
usage (559) 559
adolescent (555) 555
pharmacogenetics (545) 545
genotype (514) 514
mortality (510) 510
internal medicine (507) 507
vitamin k (500) 500
thrombin (499) 499
heparin (486) 486
heparin - therapeutic use (477) 477
aspirin - administration & dosage (476) 476
medical research (465) 465
cytochrome p-450 cyp2c9 (452) 452
cardiovascular diseases (448) 448
cohort studies (445) 445
clinical trials (444) 444
vitamin k - antagonists & inhibitors (430) 430
aryl hydrocarbon hydroxylases - genetics (424) 424
aspirin - therapeutic use (422) 422
randomized controlled trials as topic (421) 421
venous thrombosis - drug therapy (418) 418
young adult (408) 408
medicine, experimental (399) 399
algorithms (387) 387
incidence (384) 384
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12322) 12322
Japanese (254) 254
Russian (80) 80
French (51) 51
German (43) 43
Norwegian (40) 40
Portuguese (35) 35
Swedish (35) 35
Spanish (32) 32
Chinese (31) 31
Italian (29) 29
Danish (17) 17
Turkish (15) 15
Czech (14) 14
Hungarian (10) 10
Hebrew (7) 7
Polish (7) 7
Korean (6) 6
Finnish (5) 5
Croatian (2) 2
Dutch (2) 2
Arabic (1) 1
Bulgarian (1) 1
Lithuanian (1) 1
Persian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke (1970), ISSN 1524-4628, 06/2013, Volume 44, Issue 6, pp. 1676 - 1681
Background and Purpose-To estimate the cost-effectiveness of stroke prevention in patients with nonvalvular atrial fibrillation by using novel oral... 
Intracranial hemorrhage | Stroke | Anticoagulation | Markov model | Cost-effectiveness | Atrial fibrillation | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | United States | Humans | Anticoagulants - economics | Thiophenes - administration & dosage | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - economics | Stroke - epidemiology | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Administration, Oral | Morpholines - administration & dosage | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Pyrazoles - economics | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Cohort Studies | Index Medicus
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2014, Volume 111, Issue 4, pp. 575 - 582
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 03/2012, Volume 107, Issue 3, pp. 584 - 589
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2017, Volume 130, Issue 9, pp. 1015 - 1023
Abstract Renal impairment increases risk of stroke and systemic embolic events and bleeding in patients with atrial fibrillation. Direct oral anticoagulants... 
Internal Medicine | Atrial fibrillation | Direct oral anticoagulants | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dabigatran - adverse effects | Pharmaceutical Research - statistics & numerical data | Pyrazoles - therapeutic use | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Pharmaceutical Research - standards | Warfarin - adverse effects | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Thiazoles - therapeutic use | Warfarin - administration & dosage | Dabigatran - therapeutic use | Rivaroxaban - administration & dosage | Thiazoles - adverse effects | Factor Xa Inhibitors - administration & dosage | Warfarin - therapeutic use | Pyridones - administration & dosage | Pyridines - adverse effects | Rivaroxaban - adverse effects | Hemorrhage - etiology | Pharmaceutical Research - methods | Renal Insufficiency - complications | Embolism - etiology | Rivaroxaban - therapeutic use | Pyrazoles - adverse effects | Pyridines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Pyridines - administration & dosage | Embolism - complications | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Antithrombins - therapeutic use | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Factor Xa Inhibitors - therapeutic use | Pyrazoles - administration & dosage | Stroke - etiology | Pyridones - therapeutic use | Pyridones - adverse effects | Therapeutic Equivalency | Stroke (Disease) | Drugstores | Health care industry | Warfarin | Pharmacy | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9745, pp. 975 - 983
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2013, Volume 26, Issue 2, pp. 191 - 202
In the past decade, several new oral anticoagulants (NOACs) have been studied and approved for the prophylaxis and treatment of arterial and venous... 
Hematology, Oncology and Palliative Medicine | dabigatran | reversal | rivaroxaban | bleeding | apixaban | edoxaban | bleeding reversal | Life Sciences & Biomedicine | Hematology | Science & Technology | Anticoagulants - administration & dosage | Thiophenes - adverse effects | Humans | Thiazoles - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Thiazoles - adverse effects | Pyridones - administration & dosage | Rivaroxaban | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Thromboembolism - drug therapy | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Thromboembolism - pathology | Pyrazoles - adverse effects | beta-Alanine - adverse effects | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Prothrombin - analogs & derivatives | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Pyrazoles - administration & dosage | Blood Coagulation Factors - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Hemorrhage - pathology | Pyridones - adverse effects | Monoclonal antibodies | Thrombin | Warfarin | Thromboembolism | Index Medicus | Farmakologi och toxikologi | Hematologi | Klinisk medicin | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Journal Article